| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.7 | 0.006 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |